WuXi AppTec
WuXi AppTec is the contract research and manufacturing giant that makes small molecules, including ADC payloads and linkers, for much of the global cancer pipeline, and the target of the US BIOSECURE Act.
Overview
Founded by Ge Li in Shanghai; discovery chemistry, toxicology, clinical CRO and small-molecule and peptide manufacturing for most large Western pharma; co-founded JW Therapeutics with Juno. Its cell and gene therapy arm WuXi ATU was sold in 2024 to 2025 after the US BIOSECURE Act named WuXi AppTec and WuXi Biologics as companies of concern, the clearest example of geopolitics reshaping oncology supply chains.
Scorecard
All companies- approved products +6
- targets +2
- modalities +2
- regions +1
- registry trials +6
Pages like this
not linked directly; found by shared links- TrialRELIANCE
Shares Relmacabtagene autoleucel, JW Therapeutics and the tag china.
- CompanyShanghai Henlius Biotech
Shares Regulatory divergence between regions and the tag china.
- CompanyJiangsu Hengrui Pharmaceuticals
Shares Regulatory divergence between regions and the tag china.
- IdeaManufacturing-change passport: one approved CMC change accepted everywhere in 30 days
Shares Regulatory divergence between regions, Manufacturing cost and time for living and radioactive medicines.
- IdeaMutual recognition of GMP inspections for cell, gene and radiopharmaceutical plants
Shares Regulatory divergence between regions, Manufacturing cost and time for living and radioactive medicines.
- IdeaComparability by design: a digital twin and sentinel panel for cell process changes
Shares Regulatory divergence between regions, Manufacturing cost and time for living and radioactive medicines.
- IdeaHarmonise Europe's hospital exemption for academic cell therapies, with one registry
Shares Regulatory divergence between regions, Manufacturing cost and time for living and radioactive medicines.
- IdeaRegional cyclotron hubs for actinium-225 with an agreed actinium-227 impurity limit
Shares Regulatory divergence between regions, Manufacturing cost and time for living and radioactive medicines.